I now have sufficient information from the textbooks to compile all answers. Let me write comprehensive exam answers.---
π BIOCHEMISTRY EXAM ANSWERS
ββββββββββββββββββββββββ
LONG ANSWER QUESTIONS (15 Marks Each)
ββββββββββββββββββββββββ
LONG Q.1 β Urea Cycle with Reactions & Major Metabolic Disorders
INTRODUCTION
The urea cycle (also called the Krebs-Henseleit cycle) is the metabolic pathway by which the body converts toxic ammonia (NHβ) into the harmless, water-soluble compound urea, which is then excreted in the urine. It was first described by Hans Krebs and Kurt Henseleit in 1932 and occurs mainly in hepatocytes (liver cells).
- Normal blood ammonia: 30β60 ΞΌmol/L
- Normal blood urea: 20β40 mg/dL
π‘ Key Concept: Urea contains 2 nitrogen atoms β one comes from NHββΊ (free ammonia) and one from aspartate.
LOCATION
| Step | Location |
|---|
| Reactions 1 & 2 | Mitochondrial matrix |
| Reactions 3, 4 & 5 | Cytosol |
REACTIONS OF THE UREA CYCLE
The cycle has 5 main steps and involves 5 enzymes:
βοΈ STEP 1 β Formation of Carbamoyl Phosphate (Mitochondria)
Enzyme: Carbamoyl Phosphate Synthetase I (CPS-I)
NHββΊ + HCOββ» + 2 ATP β Carbamoyl Phosphate + 2 ADP + Pi
- Requires 2 ATP molecules (energy-requiring step)
- Requires allosteric activator: N-acetylglutamate (NAG)
- This is the rate-limiting (pace-making) step of the urea cycle
- CPS-I is a mitochondrial enzyme; CPS-II (cytoplasmic) is used in pyrimidine synthesis
βοΈ STEP 2 β Formation of Citrulline (Mitochondria)
Enzyme: Ornithine Transcarbamoylase (OTC)
Carbamoyl Phosphate + Ornithine β Citrulline + Pi
- Occurs in the mitochondrial matrix
- Citrulline is then transported to the cytosol in exchange for ornithine via a specific carrier (antiporter)
βοΈ STEP 3 β Formation of Argininosuccinate (Cytosol)
Enzyme: Argininosuccinate Synthetase
Citrulline + Aspartate + ATP β Argininosuccinate + AMP + PPi
- This step incorporates the 2nd nitrogen (from aspartate)
- Requires 1 ATP (cleaved to AMP + PPi, equivalent to 2 ATP worth of energy)
βοΈ STEP 4 β Cleavage of Argininosuccinate (Cytosol)
Enzyme: Argininosuccinase (Argininosuccinate Lyase)
Argininosuccinate β Arginine + Fumarate
- Fumarate enters the TCA cycle β links urea cycle to TCA cycle
- Arginine contains both nitrogens that will form urea
βοΈ STEP 5 β Hydrolysis of Arginine to Release Urea (Cytosol)
Enzyme: Arginase
Arginine + HβO β Urea + Ornithine
- Urea is released and excreted in urine
- Ornithine is regenerated and transported back into the mitochondria to start the cycle again
OVERALL SUMMARY EQUATION
NHββΊ + COβ + 3 ATP + Aspartate + 2 HβO β Urea + 2 ADP + 4 Pi + AMP + Fumarate
Energy cost = 3 ATP (2 ATP in Step 1 + 1 ATP equivalent in Step 3)
REGULATION OF THE UREA CYCLE
| Factor | Effect |
|---|
| High-protein diet | β urea cycle enzymes (induction) |
| N-acetylglutamate | Activates CPS-I (rate-limiting enzyme) |
| Starvation | β urea production due to β protein catabolism |
| Arginine | Stimulates N-acetylglutamate synthesis |
MAJOR METABOLIC DISORDERS OF THE UREA CYCLE
All disorders cause hyperammonemia, encephalopathy, and respiratory alkalosis.
| Disorder | Deficient Enzyme | Key Features |
|---|
| Hyperammonemia Type I | CPS-I | β NHβ, normal orotic acid |
| OTC Deficiency (most common) | Ornithine Transcarbamoylase | β NHβ, β orotic acid in urine (X-linked) |
| Citrullinemia | Argininosuccinate Synthetase | β citrulline in blood & urine |
| Argininosuccinic Aciduria | Argininosuccinate Lyase | β argininosuccinate in urine |
| Argininemia | Arginase | β arginine, spastic diplegia |
| HHH Syndrome | Ornithine transporter (ORC1) | Hyperornithinemia, Hyperammonemia, Homocitrullinuria |
π OTC deficiency is the most common; it is X-linked β the carbamoyl phosphate that accumulates spills into the pyrimidine pathway, causing excess orotic acid in urine.
Common Clinical Features of All Urea Cycle Disorders:
- Vomiting, lethargy, irritability
- Avoidance of high-protein foods
- Intermittent ataxia
- Severe mental retardation if untreated
- Neonates: lethargy β hypothermia β apnea β coma
Treatment:
- Low-protein diet
- Sodium benzoate / sodium phenylbutyrate (alternative nitrogen excretion pathways)
- Arginine supplementation
- Liver transplant (definitive)
LONG Q.2 β Transamination Reaction in Catabolism of Amino Acids
INTRODUCTION
Transamination is the transfer of an Ξ±-amino group from an amino acid to an Ξ±-keto acid, producing a new amino acid and a new keto acid. It is the first and most important step in the catabolism (breakdown) of most amino acids.
- Catalyzed by enzymes called Transaminases (Aminotransferases)
- Coenzyme used: Pyridoxal Phosphate (PLP) β derived from Vitamin Bβ
- The reaction is reversible β it is used in both catabolism and synthesis of amino acids
GENERAL EQUATION
Amino acidβ + Ξ±-Keto acidβ β Ξ±-Keto acidβ + Amino acidβ
Most commonly:
Amino acid + Ξ±-Ketoglutarate β Ξ±-Keto acid + Glutamate
MOST IMPORTANT TRANSAMINASE REACTIONS
1. Alanine Transaminase (ALT / SGPT)
Alanine + Ξ±-Ketoglutarate β Pyruvate + Glutamate
- Found mainly in the liver
2. Aspartate Transaminase (AST / SGOT)
Aspartate + Ξ±-Ketoglutarate β Oxaloacetate + Glutamate
- Found in the liver, heart, skeletal muscle
MECHANISM (How PLP Works)
- PLP binds to the enzyme as a Schiff base
- The amino group from the amino acid is transferred to PLP β PLP becomes Pyridoxamine Phosphate (PMP)
- PMP then donates the amino group to the keto acid β regenerating PLP
- This is called a Ping-Pong (Double Displacement) reaction
ROLE IN AMINO ACID CATABOLISM
- Transamination funnels nitrogen from many different amino acids into glutamate
- Glutamate then undergoes oxidative deamination (by glutamate dehydrogenase) to release free NHββΊ
- NHββΊ is then used in the urea cycle for disposal
Amino acids β (transamination) β Glutamate β (oxidative deamination) β NHββΊ β Urea Cycle
EXCEPTIONS (Amino acids that do NOT undergo transamination)
- Proline, Hydroxyproline, Threonine, Lysine
- These are catabolized by other pathways
SIGNIFICANCE
| Aspect | Importance |
|---|
| Metabolic | Connects amino acid, carbohydrate, and lipid metabolism |
| Clinical | ALT & AST levels are used to diagnose liver and heart disease |
| Reversibility | Allows synthesis of non-essential amino acids |
LONG Q.3 β Bile Pigments & Diseases Associated with Their Metabolism
WHAT ARE BILE PIGMENTS?
Bile pigments are colored breakdown products of heme (the iron-containing part of hemoglobin). The main bile pigments are:
- Biliverdin β green pigment (first formed)
- Bilirubin β yellow-orange pigment (main bile pigment in humans)
- Urobilinogen β colorless (formed in intestine)
- Urobilin β yellow (excreted in urine)
- Stercobilin β brown (excreted in feces, gives stool its color)
FORMATION & METABOLISM OF BILIRUBIN
Step 1 β Heme Breakdown (Spleen & RES)
Hemoglobin β Globin + Heme
Heme β (Heme oxygenase) β Biliverdin + FeΒ²βΊ + CO
Step 2 β Biliverdin to Bilirubin
Biliverdin β (Biliverdin reductase, NADPH) β Bilirubin
- Unconjugated bilirubin = fat-soluble, water-insoluble
- Transported in blood bound to albumin
- Also called indirect bilirubin
Step 3 β Hepatic Uptake & Conjugation
Bilirubin β enters hepatocyte β binds Y & Z proteins (ligandins)
Bilirubin + 2 UDP-glucuronic acid β (UDP-glucuronyl transferase) β Bilirubin diglucuronide
- This is conjugated bilirubin = water-soluble
- Also called direct bilirubin
Step 4 β Excretion into Bile
- Conjugated bilirubin is secreted into bile canaliculi β bile ducts β small intestine
Step 5 β Intestinal Conversion
Conjugated bilirubin β (gut bacteria) β Urobilinogen
- 50% reabsorbed β liver (enterohepatic circulation) or excreted in urine as urobilin
- 50% oxidized in colon β Stercobilin (gives feces brown color)
NORMAL VALUES
| Pigment | Normal Value |
|---|
| Total bilirubin | 0.3β1.2 mg/dL |
| Conjugated (direct) | 0β0.3 mg/dL |
| Unconjugated (indirect) | 0.2β0.9 mg/dL |
| Urine urobilinogen | 0β4 mg/24 hr |
DISEASES ASSOCIATED WITH BILE PIGMENT METABOLISM
1. JAUNDICE (ICTERUS) β Bilirubin > 2.5 mg/dL β visible yellow skin/eyes
| Type | Cause | Bilirubin Type β |
|---|
| Pre-hepatic (Hemolytic) | Excess RBC destruction (malaria, G6PD deficiency) | Unconjugated β |
| Hepatic (Hepatocellular) | Liver disease (hepatitis, cirrhosis) | Both β |
| Post-hepatic (Obstructive) | Bile duct obstruction (gallstones, cancer of pancreas) | Conjugated β |
2. NEONATAL JAUNDICE (Physiological)
- Newborns have immature UDP-glucuronyl transferase
- Unconjugated bilirubin rises; if severe β kernicterus (brain damage)
- Treatment: Phototherapy (converts bilirubin to water-soluble isomer)
3. GILBERT SYNDROME
- Benign autosomal dominant
- Mild β in UDP-glucuronyl transferase activity
- Mild unconjugated hyperbilirubinemia; no liver damage
4. CRIGLER-NAJJAR SYNDROME
- Severe deficiency of UDP-glucuronyl transferase
- Type I: Complete absence β fatal without liver transplant
- Type II: Partial deficiency β responds to phenobarbital
5. DUBIN-JOHNSON SYNDROME
- Defect in secretion of conjugated bilirubin into bile canaliculi (MRP2 transporter defect)
- Conjugated hyperbilirubinemia; benign
- Liver appears black on biopsy (melanin-like pigment)
6. ROTOR SYNDROME
- Similar to Dubin-Johnson but no black liver pigment
- Defect in hepatic storage of bilirubin
LONG Q.4 β Transaminases & Their Diagnostic Importance
WHAT ARE TRANSAMINASES?
Transaminases (also called aminotransferases) are enzymes that catalyze transamination β the transfer of an amino group from an amino acid to a keto acid. They require Pyridoxal Phosphate (PLP / Vitamin Bβ) as a coenzyme.
TWO CLINICALLY IMPORTANT TRANSAMINASES
1. Alanine Aminotransferase (ALT)
- Also called: SGPT (Serum Glutamate Pyruvate Transaminase)
- Reaction: Alanine + Ξ±-Ketoglutarate β Pyruvate + Glutamate
- Location: Highest in liver cytoplasm (liver-specific)
- Normal: 5β40 U/L
2. Aspartate Aminotransferase (AST)
- Also called: SGOT (Serum Glutamate Oxaloacetate Transaminase)
- Reaction: Aspartate + Ξ±-Ketoglutarate β Oxaloacetate + Glutamate
- Location: Liver, heart muscle, skeletal muscle, kidneys (less specific)
- Normal: 5β40 U/L
π Key Difference: ALT is more liver-specific; AST is also found in heart and muscle.
DIAGNOSTIC IMPORTANCE OF TRANSAMINASES
A. Liver Diseases
| Condition | ALT | AST | AST/ALT Ratio |
|---|
| Viral Hepatitis | βββ (>10Γ) | ββ | < 1 (ALT > AST) |
| Alcoholic Hepatitis | β | ββ | > 2 (De Ritis ratio) |
| Liver Cirrhosis | β | β | > 1 |
| Obstructive Jaundice | β | β | Variable |
| Fatty liver (NAFLD) | β | β | < 1 |
π De Ritis Ratio (AST/ALT): >2 in alcoholic liver disease; <1 in viral hepatitis
B. Cardiac Disease β Myocardial Infarction (Heart Attack)
| Time after MI | AST Level |
|---|
| Rises after | 6β8 hours |
| Peak | 24β48 hours |
| Returns to normal | 3β5 days |
- AST was historically used for MI diagnosis before Troponin and CK-MB became available
- AST is now replaced by troponin for cardiac diagnosis
C. Other Uses
| Disease | Finding |
|---|
| Infectious mononucleosis | β ALT & AST |
| Drug-induced hepatotoxicity (paracetamol overdose) | ββ ALT |
| Skeletal muscle disease (myopathy) | β AST |
| Pre-operative liver function | Baseline transaminase levels |
IMPORTANT POINTS
- Transaminases are released into blood when cells are damaged or destroyed
- The higher the enzyme level, the greater the cell damage
- ALT is the most sensitive and specific marker for liver cell damage
- Both enzymes together provide better diagnostic information than either alone
LONG Q.5 β Porphyrins: Types & Clinical Importance of Porphyria
WHAT ARE PORPHYRINS?
Porphyrins are complex cyclic compounds formed by the linkage of 4 pyrrole rings through methene bridges (βCH=). They have a strong ability to chelate metal ions:
- Porphyrin + FeΒ²βΊ = Heme (in hemoglobin, myoglobin, cytochromes)
- Porphyrin + MgΒ²βΊ = Chlorophyll (in plants)
HEME BIOSYNTHESIS (Porphyrin Synthesis Pathway)
Starting materials: Succinyl-CoA + Glycine
| Step | Product | Enzyme | Location |
|---|
| 1 | Ξ΄-Aminolevulinic acid (ALA) | ALA synthase (rate-limiting) | Mitochondria |
| 2 | Porphobilinogen (PBG) | ALA dehydratase | Cytosol |
| 3 | Hydroxymethylbilane | PBG deaminase | Cytosol |
| 4 | Uroporphyrinogen III | Uroporphyrinogen synthase | Cytosol |
| 5 | Coproporphyrinogen III | Uroporphyrinogen decarboxylase | Cytosol |
| 6 | Protoporphyrinogen IX | Coproporphyrinogen oxidase | Mitochondria |
| 7 | Protoporphyrin IX | Protoporphyrinogen oxidase | Mitochondria |
| 8 | Heme | Ferrochelatase (+ FeΒ²βΊ) | Mitochondria |
π Rate-limiting enzyme: ALA synthase, activated by succinyl-CoA; inhibited by heme (feedback inhibition)
WHAT IS PORPHYRIA?
Porphyria is a group of metabolic disorders caused by deficiency of enzymes in the heme biosynthesis pathway, leading to accumulation of porphyrin precursors (ALA, PBG) or porphyrins in tissues and their excess excretion in urine/feces.
CLASSIFICATION OF PORPHYRIA
By Site of Main Overproduction:
| Type | Site |
|---|
| Hepatic Porphyrias | Porphyrins produced mainly in liver |
| Erythropoietic Porphyrias | Porphyrins produced mainly in bone marrow |
TYPES OF PORPHYRIA & CLINICAL FEATURES
| Porphyria | Enzyme Defect | Type | Main Features |
|---|
| Acute Intermittent Porphyria (AIP) | PBG deaminase | Hepatic | Abdominal pain, neuropsychiatric symptoms, NO skin lesions |
| Porphyria Cutanea Tarda (PCT) | Uroporphyrinogen decarboxylase | Hepatic | Most common; skin blistering in sun-exposed areas |
| Congenital Erythropoietic Porphyria (CEP) | Uroporphyrinogen III synthase | Erythropoietic | Severe photosensitivity, red urine, hemolytic anemia |
| Erythropoietic Protoporphyria (EPP) | Ferrochelatase | Erythropoietic | Burning pain in skin on sun exposure |
| Hereditary Coproporphyria | Coproporphyrinogen oxidase | Hepatic | Neuropsychiatric + skin lesions |
| Variegate Porphyria | Protoporphyrinogen oxidase | Hepatic | Both skin and neuropsychiatric symptoms |
| ALA Dehydratase Porphyria (ADP) | ALA dehydratase | Hepatic | Very rare; neurological |
CLINICAL FEATURES IN DETAIL
Acute (Neurovisceral) Symptoms β seen in hepatic porphyrias:
- Severe colicky abdominal pain (most common complaint)
- Vomiting, constipation
- Neuropsychiatric symptoms: anxiety, confusion, psychosis, seizures
- Motor neuropathy: weakness, paralysis
- Autonomic features: tachycardia, hypertension
- Urine turns dark/red-brown on standing (oxidation of PBG/ALA)
Cutaneous Symptoms β seen in porphyrias with porphyrin accumulation:
- Photosensitivity: burning, itching, blistering on sun-exposed skin
- Skin fragility and scarring
PRECIPITATING FACTORS (Important for Exams)
- Drugs: barbiturates, sulfonamides, alcohol, OCPs (induce ALA synthase)
- Fasting / starvation
- Infections
- Hormones (progesterone)
DIAGNOSIS
| Test | Finding |
|---|
| Urine | ββ ALA, PBG (turns red on standing) |
| Watson-Schwartz test | Positive for urobilinogen/PBG |
| Fecal porphyrins | β in variegate porphyria |
| Enzyme assay | Specific enzyme deficiency |
TREATMENT
- Avoid triggers (drugs, fasting, alcohol)
- Glucose/carbohydrate loading (suppresses ALA synthase)
- Heme infusion (Hematin) β suppresses ALA synthase by feedback inhibition
- Symptomatic: analgesics, beta-blockers for pain and tachycardia
- Porphyria cutanea tarda: Phlebotomy, chloroquine
ββββββββββββββββββββββββ
SHORT ANSWER QUESTIONS (5 Marks Each)
ββββββββββββββββββββββββ
SHORT Q.1 β Transamination Reaction in Catabolism of Amino Acids
Transamination is the transfer of the Ξ±-amino group of an amino acid to an Ξ±-keto acid, forming a new amino acid and a new keto acid.
Enzyme: Transaminases (Aminotransferases)
Coenzyme: Pyridoxal Phosphate (PLP) β from Vitamin Bβ
General Reaction:
Amino Acid + Ξ±-Ketoglutarate β Ξ±-Keto Acid + Glutamate
Key Examples:
ALT reaction (in liver):
Alanine + Ξ±-Ketoglutarate β Pyruvate + Glutamate
AST reaction (in liver & heart):
Aspartate + Ξ±-Ketoglutarate β Oxaloacetate + Glutamate
Importance in Catabolism:
- It removes the amino group from amino acids as the first step of catabolism
- All amino groups are channeled into glutamate
- Glutamate β undergoes oxidative deamination β releases NHββΊ
- NHββΊ enters the urea cycle and is excreted as urea
- The remaining carbon skeleton enters TCA cycle or gluconeogenesis
Mechanism (Ping-Pong):
- PLP binds amino group β becomes PMP β PMP transfers amino group to keto acid β PLP regenerated
SHORT Q.2 β Phenylketonuria and Alkaptonuria
A. PHENYLKETONURIA (PKU)
Definition: An autosomal recessive disorder due to deficiency of phenylalanine hydroxylase (PAH), leading to accumulation of phenylalanine.
Enzyme Deficient: Phenylalanine hydroxylase (converts Phe β Tyrosine)
Biochemistry:
Phenylalanine β (PAH) β Tyrosine β this step is blocked
Accumulated Phe β converted to phenylpyruvate, phenylacetate, phenyllactate (excreted in urine β "mousy odor")
Clinical Features:
- Normal at birth
- Progressive intellectual disability (mental retardation)
- Hyperactivity, seizures
- Fair skin, blond hair, blue eyes (β melanin due to β tyrosine)
- Mousy/musty odor of urine
- Eczema
Diagnosis:
- Guthrie test (newborn heel-prick screening)
- Blood phenylalanine > 20 mg/dL (normal: 1β2 mg/dL)
Treatment:
- Low phenylalanine diet (restrict natural protein)
- Tyrosine supplementation
- Sapropterin (BHβ analogue) for mild cases
B. ALKAPTONURIA
Definition: Autosomal recessive disorder due to deficiency of homogentisate oxidase, leading to accumulation of homogentisic acid.
Enzyme Deficient: Homogentisate-1,2-dioxygenase (homogentisate oxidase)
Biochemistry:
Phenylalanine β Tyrosine β homogentisic acid β (enzyme blocked) β accumulates
Homogentisic acid oxidized to alkapton (benzoquinone acetic acid) β deposited in tissues
Clinical Features (triad):
- Dark urine (turns black on standing/exposure to air) β due to oxidation of homogentisic acid
- Ochronosis β dark-brown/black pigment deposits in connective tissue (cartilage, sclerae, skin)
- Arthritis β degenerative joint disease (especially spine and large joints) in later life
Diagnosis:
- Urine turns dark on alkalinization or standing
- Ferric chloride test on urine: blue-black color
- Chromatography: β homogentisic acid
Treatment:
- Low phenylalanine and tyrosine diet
- High-dose Vitamin C (reduces ochronosis)
- Nitisinone (NTBC) β inhibits earlier enzyme in pathway
SHORT Q.3 β What is Porphyria?
Definition:
Porphyrias are a group of inherited (or acquired) metabolic disorders caused by deficiencies of enzymes in the heme biosynthesis pathway, leading to excessive accumulation and excretion of porphyrins or their precursors (ALA, PBG).
Classification:
| Type | Site | Example |
|---|
| Hepatic | Liver | Acute Intermittent Porphyria (AIP), PCT |
| Erythropoietic | Bone marrow | Congenital Erythropoietic Porphyria (CEP) |
Clinical Features:
- Neurovisceral (Acute): Severe abdominal pain, neuropsychiatric symptoms, peripheral neuropathy
- Cutaneous: Photosensitivity, skin blistering, scarring
Most Common: Porphyria Cutanea Tarda (PCT)
Most Severe Acute Form: Acute Intermittent Porphyria (AIP)
Key Diagnostic Sign:
- Urine turns red/port wine colored on standing (oxidation of PBG in AIP)
- Watson-Schwartz test: positive
Treatment:
- Avoid triggers (alcohol, drugs, fasting)
- IV glucose (carbohydrate loading)
- Hematin infusion (suppresses ALA synthase)
SHORT Q.4 β Jaundice: Definition & Types
DEFINITION
Jaundice (Icterus) is a yellowish discoloration of the skin, mucous membranes, and sclerae (whites of the eyes) caused by accumulation of bilirubin in the body. It becomes clinically visible when serum bilirubin exceeds 2β3 mg/dL (normal < 1.2 mg/dL).
TYPES OF JAUNDICE
1. PRE-HEPATIC JAUNDICE (Hemolytic Jaundice)
Cause: Excessive destruction of red blood cells β excess bilirubin production beyond liver's conjugation capacity
Examples: Malaria, sickle cell anemia, G6PD deficiency, hemolytic disease of newborn, transfusion reactions
| Lab Finding | Result |
|---|
| Serum bilirubin | β Unconjugated |
| Urine bilirubin | Absent (unconjugated can't pass glomerulus) |
| Urine urobilinogen | ββ |
| Fecal stercobilin | β (dark stools) |
| ALT/AST | Normal |
2. HEPATIC JAUNDICE (Hepatocellular Jaundice)
Cause: Liver cell damage reduces ability to take up, conjugate, or secrete bilirubin
Examples: Viral hepatitis (A, B, C), alcoholic hepatitis, cirrhosis, drug toxicity (paracetamol), leptospirosis
| Lab Finding | Result |
|---|
| Serum bilirubin | β Both conjugated & unconjugated |
| Urine bilirubin | Present (conjugated is water-soluble) |
| Urine urobilinogen | Variable (β or β) |
| ALT/AST | ββ (liver cell damage) |
| Alkaline phosphatase | Mildly β |
3. POST-HEPATIC JAUNDICE (Obstructive/Cholestatic Jaundice)
Cause: Obstruction of bile flow β conjugated bilirubin regurgitates into blood
Examples: Gallstones in common bile duct, carcinoma of head of pancreas, bile duct stricture, cholangitis
| Lab Finding | Result |
|---|
| Serum bilirubin | β Conjugated (direct) |
| Urine bilirubin | ββ (dark, tea-colored urine) |
| Urine urobilinogen | Absent (no bilirubin reaches gut) |
| Fecal stercobilin | β or absent (clay/pale stools) |
| Alkaline phosphatase | βββ |
| ALT/AST | Mildly β |
4. NEONATAL JAUNDICE (Physiological)
- Appears day 2β3 after birth, resolves by day 7β10
- Due to immature UDP-glucuronyl transferase + increased RBC breakdown
- Unconjugated hyperbilirubinemia
- If severe β Kernicterus (bilirubin deposits in brain β brain damage)
- Treatment: Phototherapy (converts bilirubin to water-soluble isomer)
QUICK COMPARISON TABLE
| Feature | Pre-hepatic | Hepatic | Post-hepatic |
|---|
| Bilirubin | Unconjugated β | Both β | Conjugated β |
| Urine color | Normal | Dark | Dark (tea-colored) |
| Stool color | Dark | Normal | Pale/clay |
| Urine urobilinogen | ββ | Variable | Absent |
| Urine bilirubin | Absent | Present | Present |
| ALT/AST | Normal | ββ | Mildly β |
| ALP | Normal | β | βββ |
SHORT Q.5 β Normal Blood Urea Level & Conditions with Elevated Urea
NORMAL BLOOD UREA LEVEL
| Parameter | Normal Value |
|---|
| Blood Urea | 20β40 mg/dL |
| Blood Urea Nitrogen (BUN) | 8β20 mg/dL |
| Blood Ammonia | 30β60 ΞΌmol/L |
π BUN = Urea Γ 0.46 (since nitrogen is ~46% of urea's molecular weight)
CONDITIONS WITH ELEVATED BLOOD UREA (Azotemia/Uremia)
1. PRE-RENAL CAUSES (β Blood flow to kidney)
- Dehydration (vomiting, diarrhea, excessive sweating)
- Congestive heart failure
- Shock / hemorrhage
- Burns
- β protein catabolism (fever, trauma, starvation)
- High-protein diet
2. RENAL CAUSES (Kidney disease)
- Acute Kidney Injury (AKI) β e.g., tubular necrosis, nephritis
- Chronic Kidney Disease (CKD) / Chronic Renal Failure β Most common cause of chronically elevated urea
- Glomerulonephritis
- Pyelonephritis
3. POST-RENAL CAUSES (Obstruction of urine flow)
- Urinary tract obstruction (kidney stones, enlarged prostate)
- Bladder cancer
- Ureteral obstruction
TWO SPECIFIC CONDITIONS FOR EXAM (Most Common Asked):
| Condition | Why Urea is Elevated |
|---|
| Chronic Renal Failure (CRF) | Kidneys fail to excrete urea β accumulates in blood |
| Dehydration | β renal blood flow β β GFR β β urea excretion |
π‘ Clinical Note: Severely elevated blood urea (uremia) causes symptoms like nausea, vomiting, confusion, pericarditis, and altered consciousness.
ββββββββββββββββββββββββ
π QUICK REVISION TABLE β All Topics
| Topic | Key Point |
|---|
| Urea Cycle | 5 steps, liver, 3 ATP used, ornithine is recycled |
| Rate-limiting enzyme of urea cycle | CPS-I (activated by N-acetylglutamate) |
| Most common urea cycle disorder | OTC deficiency (X-linked, β orotic acid in urine) |
| Transamination coenzyme | Pyridoxal Phosphate (Vitamin Bβ) |
| Most liver-specific transaminase | ALT (SGPT) |
| AST/ALT ratio > 2 | Alcoholic hepatitis (De Ritis ratio) |
| Main bile pigment | Bilirubin |
| Rate-limiting enzyme of porphyrin synthesis | ALA synthase |
| Most common porphyria | Porphyria Cutanea Tarda (PCT) |
| Porphyria with port wine urine | Acute Intermittent Porphyria (AIP) |
| Normal bilirubin | < 1.2 mg/dL |
| Clay/pale stools | Obstructive jaundice |
| Normal blood urea | 20β40 mg/dL |
| PKU deficient enzyme | Phenylalanine hydroxylase |
| Alkaptonuria deficient enzyme | Homogentisate oxidase |
| Alkaptonuria triad | Dark urine + ochronosis + arthritis |
*Sources: Basic Medical Biochemistry β A Clinical Approach 6e; Harper's Illustrated Biochemistry 32nd Ed; Lippincott Illustrated Reviews Biochemistry 8th Ed; Henry's Clinical Diagnosis and Management by Laboratory Methods.*Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.